Congenital/infant acute myeloid leukemia (AML) has poor outcome despite aggressive
therapy with rare instances of spontaneous remission. The two well-known entities with …

ANSWER Skin biopsy revealed infiltration of blasts that were positive for CD43, CD68,
CD33, CD4, and myeloperoxidase suggestive of AML-M5. Her complete blood count …

Congenital leukemia is an extremely rare disorder that is diagnosed within the first 28 days
of birth. 1 Common clinical features of congenital leukemia include prominent …

Congenital leukemia is rare disease with an incidence of one to five cases per million births.
Transient abnormal myelopoiesis (TAM), also called transient myeloproliferative disorder, is …

In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …

Congenital leukemia is uncommon and excluding transient myeloproliferation associated
with Down syndrome, makes up approximately 1% of childhood leukemias. A newborn boy …

Dear Editor, Congenital leukemia comprises less than 1% of childhood leukemia1 and skin
infiltration by leukemic cells (known as “leukemia cutis”) only occasionally precedes …

Background Congenital acute nonlymphoblastic leukemia (cANLL) is an extremely rare
event and represents only 0.5–1% of the leukemias in the first year of life. It is usually more …

Congenital acute myeloid leukemia (AML), and especially AML-M6 is a rare disease with a
poor prognosis. Moreover, reports of treatment outcome of congenital AML-M6 in premature …

Our patient was born full-term to a healthy 36-year-old mother by a Cesarean Section. At
birth, two round purpuric lesions, one on the chest (2.2 Â 1.5 cm; Fig. 1 A) and the other on …